August 27, 2016 2:17 PM ET

Biotechnology

Company Overview of Sangamo Biosciences Inc.

Executive Profile

Keith R. Yamamoto Ph.D.

Member of Scientiic Advisory Board, Sangamo Biosciences Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 3 different industries.

See Board Relationships
----

Background

Dr. Keith R. Yamamoto, Ph.D., founded the journal Molecular Biology of the Cell and served as an Associate Editor, Editor, and Editor-in-Chief from 1989 to 2003. Dr. Yamamoto has been the Chairman of Scientific Advisory Board and Member of Scientific Advisory Board of Sirna Therapeutics Inc. from March 2005 to 2007. He oversees the Yamamoto Lab, which is interested in mechanisms by which gene transcription is regulated in different cell types and physiological (or pathological) ...

Corporate Headquarters

501 Canal Boulevard
Richmond, California 94804

United States

Phone: 510-970-6000
Fax: 510-236-8951

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
Princeton University
Post-Doctoral Training
University of California-San Francisco
Bachelor's Degree 1968
Iowa State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
David M. Pernock Chairman, Chief Executive Officer and President
Fibrocell Science, Inc.
$490.0K
Kenneth T. Mills Chief Executive Officer, President, Director and Member of Disclosure Committee
Regenxbio Inc.
$775.0K
Daniel B. Soland Chief Executive Officer, Member of Management Board and Executive Director
uniQure N.V.
--
Katrine S. Bosley Chief Executive Officer, President and Director
Editas Medicine Inc.
$386.2K
Steven M. Paul M.D.Chief Executive Officer, President and Director
Voyager Therapeutics, Inc.
$450.0K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sangamo Biosciences Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.